"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in the Syrian Arab Republic. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In the Syrian Arab Republic, the assessment looked at eight functions: medicines registration, licensing of pharmaceutical establishments, inspection of pharmaceutical establishments, promotion, selection, clinical trials, procurement and distribution"
The objectives of this review are to: assess the impact of conflict on the health of people in affected countries of the Region; document how conflict affects social determinants, and thus results in adverse health outcomes; present the results of an innovative qualitative study that captures civilian suffering and resilience in a conflict setting, through collaboration with civil society organizations; identify some examples of activities and interventions that may help to mitigate the impact of these conflicts on the health and well-being of affected populations; and identify policy implications. The study identifies three social determinants that have a bearing on health and are peculiar to a conflict setting: the loss of human rights, breaches of medical neutrality, and progression from stress to distress and disease that results from constant, unremitting exposure to a life-threatening situation. This review was requested by the Commission on the Social Determinants of Health
The official health journal published by the Eastern Mediterranean Regional Office of the WHO. It is a forum for the presentation and promotion of new policies and initiatives in health services, and for the exchange of ideas, concepts, epidemiological data, research findings and other information, with speical reference to the Region. All articles are peer reviewed
Printed copies by subscription
Source e-bulletin on Disability and Inclusion